Key malaria facts
Source: WHO
- Cases, 2010
- Globally: 219 million
80% of estimated malaria cases occur in 17 countries
40% of estimated malaria cases are in the Democratic Republic of the Congo, India and Nigeria. - Deaths, 2010
- Globally: 660 000
91% of deaths were in Africa
86% of deaths were in children under 5 years of age
80% of estimated malaria deaths occur in just 14 countries. - Population at risk
- 3.3 billion (half of the world population)
- Affected countries
- 104 endemic countries in 2012
Six countries account for 47% of malaria cases, (an estimated 103 million)
Nigeria
Democratic Republic of the Congo
United Republic of Tanzania
Uganda
Mozambique
Cote d'Ivoire - Progress
- Malaria mortality rates have fallen since 2000
Globally: by more than 25%
Africa: by 33 %
50 countries are on track to reduce their malaria case incidence rates by 75%, in line with World Health Assembly and Roll Back Malaria targets for 2015. These 50 countries only account for 3% (7 million) of the total estimated malaria cases. - Impact
- Over 1.1 million lives have been saved over the last decade.
274 million cases have been averted between 2001 and 2010.
The majority of cases averted (52%) and lives saved (58%) are in the 10 countries which had the highest estimated malaria burdens in 2000. - Required health expenditure
- $6.8 billion is needed between 2013 and 2015 to fund vital interventions like mosquito nets; diagnostic tests and medicines in Africa.
Of these, $3.2 billion has been mobilised or committed from Africa governments and international partners.
The current gap for malaria control in Africa from 2013-2015 amounts to $3.6 billion. $2.4 billion is urgently needed to maintain coverage in 8 priority African countries, currently facing severe shortages. - Economic cost
- Direct: USD 12 billion per year in direct losses,
lost 1.3% of GDP growth per year for Africa. - Current level of coverage (2010)
- Treatment: In 2011, 278 million courses of artemisinin-based combination therapies (ACTs) were procured by the public and private sectors in endemic countries – up from 182 million in 2010, and just 11 million in 2005.
Nets: dropped from a peak of 145 million in 2010 to an estimated 66 million in 2012. A massive scale-up is needed in 2013 to prevent a decrease in net coverage and resurgences.
IRS (indoor residual spraying): In 2011, 153 million people were protected by indoor residual spraying (IRS) around the world, or 5% of the total global population at risk.
Diagnostics: The number of rapid diagnostic tests delivered to endemic countries increased dramatically from 88 million in 2010 to 155 million in 2011. This was complemented by a significant improvement in the quality of tests over time. - MDGs that could be impacted by addressing malaria problem
- MDG 1 – Eradicating extreme poverty and hunger
MDG 2 – Achieve universal primary education
MDG 4 – Reduce child mortality
MDG 5 – Improve maternal health
MDG 6 – Combat HIV/AIDS, malaria and other diseases
MDG 8 – global partnerships for development and access to affordable drugs - Costs of interventions
- Long-lasting insecticidal net that lasts three years: US$ 1.39 per person per year of protection
Course of artemisinin-based combination therapy (ACT) for an adult: US$ 0.90 - 1.40
Course of artemisinin-based combination therapy (ACT) for a young child: US$ 0.30 - 0.40
Rapid diagnostic test: US$ 0.50
Source: World Malaria Report 2012 Fact Sheet, Global Malaria Action Plan (2008)